Haku Bio
Arlington, US · Founded 2026 · Delaware corporation
Founders & leadership
SM
Sandy MongExecutive
Board
BL
Bill LundbergBoard director
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 2 rounds · 2026
▶$1.5MraisedJun 2026 · 6 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJun 2026 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bill LundbergDirector
- Sandy MongExecutive Officer, Director
- Offering amount
- $2.7M
- Amount sold
- $1.5M
- Minimum investment
- $100K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
▶$210KraisedMar 2026 · 2 investors · BiotechnologyRule 506(b)
▶$210KraisedMar 2026 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bill LundbergDirector
- Sandy MongExecutive Officer, Director
- Amount sold
- $210K
- Minimum investment
- $100K
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Haku Bio raised?
- Haku Bio has disclosed $1.7M raised across 2 rounds.
- Where is Haku Bio headquartered?
- Haku Bio is headquartered in Arlington, US.